000 02203cam a2200361 a 4500
003 EG-GiCUC
005 20250223030615.0
008 120421s2011 ua d f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aM.Sc
099 _aCai01.11.18.M.Sc.2011.Az.C
100 0 _aAzza Shehata Ragab Sarhan
245 1 0 _aComparative study between myeloablative conditioning and reduced intensity conditioning regimens for allogenic stem cell transplantation in myelodysplastic syndromes /
_cAzza Shehata Ragab Sarhan ; Supervised Omar Abdelrahman Fahmy , Mohamed Abdelmooti Samra , Raafat Mohamed Abdelfattah
246 1 5 _aزرع النخاع باستخدام العلاج الكيميائي المدمر لخلايا النخاع العظمي مقارنة باستخدام العلاج الكيميائي مخفف الشدة في علاج متلازمة خلل نمو النخاع العظمي
260 _aCairo :
_bAzza Shehata Ragab Sarhan ,
_c2011
300 _a192 P. :
_bcharts ;
_c25cm
502 _aThesis (M.Sc.) - Cairo University - Faculty of Medicine. - Department of Internal Medicine
520 _aStem cell transplantation offers potentially curative therapy for patients with myelodysplastic syndrome. A broad scale regimens, ranging from "modified" conventional to reduced intensity to non-myeloablative regimens, has been developed and used successfully; one size does not appear to fit all. Rather, patient age, co-morbid conditions, disease stage, ferretin level, presence and severity of myelofibrosis, non-transplant chemotherapy, type of donor, source of stem cell, and other factors, all affect the decision regarding transplantation and impact on outcome
530 _aIssued also as CD
653 4 _aConditioning regimen
653 4 _aMyelodysplastic syndromes
653 4 _aNonmyeloablative
700 0 _aMohamed Abdelmooti Samra ,
_eSupervisor
700 0 _aOmar Abdelrahman Fahmy ,
_eSupervisor
700 0 _aRaafat Mohamed Abdelfattah ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
902 _a2
905 _aNazla
_eRevisor
905 _aSamia
_eCataloger
942 _2ddc
_cTH
999 _c38221
_d38221